Select relapsed/refractory lymphoid malignancies

Clinical trials for Select relapsed/refractory lymphoid malignancies explained in plain language.

Never miss a new study

Get alerted when new Select relapsed/refractory lymphoid malignancies trials appear

Sign up with your email to follow new studies for Select relapsed/refractory lymphoid malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New pill for tough blood cancers tested in early trial

Disease control Stopped early

This early-stage study tested an oral drug called AUR104 in 9 adults with certain blood cancers (lymphomas and leukemia) that had come back or stopped responding to treatment. The main goal was to check the drug's safety and how the body processes it. The trial was terminated ear…

Matched conditions: SELECT RELAPSED/REFRACTORY LYMPHOID MALIGNANCIES

Phase 1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

Select relapsed/refractory lymphoid malignancies

Get alerted when new Select relapsed/refractory lymphoid malignancies trials appear

New pill for tough blood cancers tested in early trial